{"name":"Aktis Oncology, Inc.","slug":"aktis-oncology-inc","ticker":"","exchange":"","domain":"aktisoncology.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNY2lVWklRVUVHUV9RaHNpSk1hSTV5OEl2azNmaGViWWVGcmdTOC1CYThHSHpoeDByMHllb1U4dXJJaThJaUZodk9EUU53Z09OTkNkZ3o2TlBvcmplUENQaGxDOGdLTVB5X1MyNE80WmtwcHAzOU9sTERBUDN5N3BjZFJGYUszbjN2c0hhNFJkQ1NGS1gtWDF5ZWV6NkxoQV8tMXN2ZmZLbEw?oc=5","date":"2026-03-30","type":"pipeline","source":"Stock Titan","summary":"Aktis Oncology (NASDAQ: AKTS) outlines miniprotein alpha radiopharma strategy - Stock Titan","headline":"Aktis Oncology (NASDAQ: AKTS) outlines miniprotein alpha radiopharma strategy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxOXzc4NDdBQTVvMUVMd3lsdDBwR0Q4QU9vcktwVzFHa2hFVVJ4amoxczBEVThFRDlNcnZXTERzbld0SmV3eG9HX0Q3WnVpbzBwcFpKN00ya2RmU0FDYkZiaVhYRXlocXN1YVcxTWcyVzg3NGQ3Q2hxNl91aGdUNXp1bmZhUXljWWhWM0RHbjk4VjU5UDZiRlpkS1Jyc1VrSU0?oc=5","date":"2026-01-12","type":"pipeline","source":"The Pharma Letter","summary":"Aktis Oncology’s IPO tests reopening of biotech markets - The Pharma Letter","headline":"Aktis Oncology’s IPO tests reopening of biotech markets","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxOU3FvcWRwZFNkOWFBQ1hEQ08zaVdxSHhJd2hSMTRxVm1uQU9LcjFjcW1fWmtQSHdRSGJ2c0ZlTEs4MjBvZjdSbDEweUo1U3JnbTF0dDhfLVZLSDExN1UxX3JCSTdLQUJYNy1oX01OY1dBbS02dksxMEZBUkpMemdFcTN2TTgzYTlHYUt5a05IaTV6SGkxSjNZTWRDYWVzUQ?oc=5","date":"2026-01-09","type":"pipeline","source":"fiercebiotech.com","summary":"1st biotech IPO of 2026 sees Aktis bring in $318M via upsized offering - fiercebiotech.com","headline":"1st biotech IPO of 2026 sees Aktis bring in $318M via upsized offering","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxPakotSHg0RFczelVDdktPNUdNYmo2YWFrUVI4NS1kclRYZDVWTXdKRTNfRTNLcjBpNmY5cDVyUVFqSGdxMm4zaVFyUkNwODVaT012RjRXZlpycjBHWU4tOXlCU1FxUUNETTlUNVdPWnc3elMycFdZaFFkc1hiUHdLX3hoamdDMVBlbmZlUHJrS0NMR0E?oc=5","date":"2026-01-09","type":"pipeline","source":"BioWorld News","summary":"Aktis raises $318M in first biopharma IPO of 2026 - BioWorld News","headline":"Aktis raises $318M in first biopharma IPO of 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQckRwNGNHdFZuV20zeTRQbFJqMU5kQVV0a3ZyMldoN19Gb05la1hCa3VPNThCMTJJb2lRMVc4RTlvYURwQ1hMYjlUdWI1Wkpjd1pCbTREdFkwLVBobUQwSWxHT0p2MlRCTzJTYTBRVG8xa0FPaEVlUU9ReEJxZGxmVHZJd0I3Y3oxM0s2TnZLaVI?oc=5","date":"2026-01-08","type":"pipeline","source":"BioPharma Dive","summary":"Aktis raises $318M in 2026’s first biotech IPO - BioPharma Dive","headline":"Aktis raises $318M in 2026’s first biotech IPO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxQMFdnZE50c2pjQV9mYTZaQ3NmVUM5VXk0czZhZldxLWVWeGdFNjRtc0p1WmNlNk90UWxzWFN0WU5kaHloeGhpa0x3TnJObkx5S1RrNDNMZzBWSjZUT1NhQ3lweTU3NXdHMFNxSzNGSXo3cVk0NG5yTDJENGJEUnZEQl8yZGhNWDdVaHRmZ2ZNNTdubGkzYmtmV3dfS004UFJJcks0NEpHR2M2UVFLcGIyYmhTd3hKVGctc21RWUhHQ1o0Z1Ytem1r?oc=5","date":"2026-01-07","type":"pipeline","source":"Reuters","summary":"Aktis Oncology secures Lilly as anchor investor for upsized US IPO - Reuters","headline":"Aktis Oncology secures Lilly as anchor investor for upsized US IPO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxOWXdjcUhMSzZkVDlkQjdmOHhpMUtJNlkxcjlsZGQ4cm03UmE1SDZDQVVqU0hmakQ2SnZtMENfa0R0TlRZUlVBUVNsSkt4Z1d0VmIybDJoc2w3QnE5dFBXWV90YU9VMS1Yd0dsUEtxU2xEVTVFUmJrTWRoNXBGdDlMTGJyUjJSVzhkQWx6dWQyNmhOQ0tnelVBUng5cjJBRWRTXzlHOVBiRQ?oc=5","date":"2026-01-06","type":"pipeline","source":"Pharmaceutical Technology","summary":"Aktis Oncology kicks 2026 IPO cycle off with $210m target - Pharmaceutical Technology","headline":"Aktis Oncology kicks 2026 IPO cycle off with $210m target","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxQaTVSVDduSTFtVURhNnhDX2FqYTFhTG1ZQV9DUkJkUzAxaFVseDJtWXVxY2l4bkFvMU1JZXVtOEU0THNBWHo3R2xpOVpsd3FZVnRrLXBiUVpIY1lDSVVsQnV2N21qV3c3cm15Q1NaR0EwRjduZmFZQWhhenczS1RvU3B3MkstRDEtSDBIc3lWd21IZ0tPTVdOajlrN3VhaTFTWnJId2ptRUlGYWN4WENZLUJNdU5fT0s2OHVfM1BxUlZTNmI2cEhqMEhla0lvS2I1eDA1dTdXN213NzQtenc?oc=5","date":"2026-01-05","type":"pipeline","source":"Reuters","summary":"MPM BioImpact-backed Aktis Oncology seeks up to $840 million valuation in US IPO - Reuters","headline":"MPM BioImpact-backed Aktis Oncology seeks up to $840 million valuation in US IPO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxNV2UtR2dGQ3VhYXR6WVhPZTkwNUR0eGs1SE1fbTVuWjNSVjJFN1dfQ21pMjRGeF95RzhHUjVzX2gzanJiZFZwSVBvVUVoSE5JRTdXMmxjLTEtdFZiMmRZMFYwUmppbHh6WEhNNU5XdU54TlNvc3FiRzdJTGJsRWhBQUE1XzRPZHV5c0ItaWlYZFpqVTg?oc=5","date":"2025-12-23","type":"pipeline","source":"seekingalpha.com","summary":"Lilly-backed radiopharma startup Aktis seeks U.S. IPO (AKTS:Pending) - seekingalpha.com","headline":"Lilly-backed radiopharma startup Aktis seeks U.S. IPO (AKTS:Pending)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxNcU5WR0F0TlJaemJWQngyWkJPUmkzM05BTDd0dGJCZFp4RkFRZ08tSEY4ekowNlZmVDlIci1CNGp6T0N3dW1tYVZaQTI3dmJQa0xqZ3hKVElOMHZNVWo2UTdxZjZTZW5TVy1pWWZLcC1ocjNfRndqYV9VWnh2bjhLQ2ZiM0xHZkVhN1NDYTRfbmRIbk5aNUdrLUdyTDFuWGox?oc=5","date":"2025-12-22","type":"pipeline","source":"BioPharma Dive","summary":"Radiopharmaceutical specialist Aktis seeks an IPO - BioPharma Dive","headline":"Radiopharmaceutical specialist Aktis seeks an IPO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxPb3pfOTZBUUhYd0FYS1JJam0wRWI2Q3BFc2ptVjFzUnY2bFQ1akY3UDY5aFJwTjZlQl83amhjUjZOVElkV0RzS2Q1QVNZV3Y0VS12X1ltNUlIUE9zZUlJdnVCaFJvbmpOZ0RRUGlRS0FpYkdMX1FYNVl5c2NuRy0zX1V1eER2Y2MtY0p3ek11VlpLbklabVhRc2U2NzZnVkVLRUp3eEVLS3pqbWRKMURqSTBRUEZhaldzT3JOdGRURjRiUQ?oc=5","date":"2025-12-19","type":"pipeline","source":"Reuters","summary":"Aktis Oncology files for US IPO as biotech listings rebound - Reuters","headline":"Aktis Oncology files for US IPO as biotech listings rebound","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxQMDdQdVJ3MjdVTjhqak5EYmU5dEJsRjZ0TmhleFlyemUwWXVQNEN3enRkMDVYeWgzZ0doN0h2QTZYQnZ2NEZ6T1Rwd3BwSHdCanV6TV9XNGR2NkRScWs0LU9BT0swWll6M1YyTWdjZi1zRnB3b2dEZ0QyNTJ0LTlUcDhyZ0NBaUxGcW9vSlpfbE5hb2RzNXp6NDBzdklDR2IyUy0xdk1ONktZTDJG?oc=5","date":"2025-11-05","type":"pipeline","source":"Contract Pharma","summary":"Aktis Oncology Appoints Kyle Kuvalanka Chief Financial Officer - Contract Pharma","headline":"Aktis Oncology Appoints Kyle Kuvalanka Chief Financial Officer","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}